U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739342) titled 'Evaluating the Occurrence of DKA in People With Type I Diabetes' on July 28.

Brief Summary: This study will evaluate the occurrences of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with Type I diabetes while managing diabetes with Abbott's Continuous Monitoring Systems.

Study Start Date: Sept., 2026

Study Type: OBSERVATIONAL

Condition: Type 1 Diabetes

Intervention: DEVICE: Abbott Continuous Dual Glucose Ketone Monitoring System

Participant will utilize the Abbott Continuous Dual Glucose Ketone Monitoring System in place of the Standard of Care

Recruitment Status: NOT_YET_RECRUITING

Sponsor: A...